91ÖĆƬł§

Skip to main content

Tania de la Fuente, Ph.D.


Department of Health Sciences, Nursing and Public Health
Chemistry

Education

Ph.D., Medicinal Chemistry, Universidad Complutense de Madrid
M.Sc. Chemistry , San Diego State University
B.A. Chemistry, University of San Diego
B.A. Biology, University of San Diego

Practice Areas

  • Medicinal Chemistry
  • Serotonin
  • 5-HT6 receptor

Publications and Media Placements

Queiros, G. W., GarcĂ­a, L., de la Fuente, T., GĂłmez de Salazar, J.M., Criado, A. J. Metallographic Interpretation of the Morphology of the Very Old Pearlite; Archives of Physics Research, 2019, 10 (1): 42-51.

łŇ´Ç˛Ôłúá±ô±đłú-łŐ±đ°ů˛ą&˛Ô˛ú˛ő±č;J. A., Medina R., Martin-Fontecha M., González A., de la Fuente T., Vázquez-Villa H., GarcĂ­a-Cárceles J, Botta J., McCormick P. J., Benhamu B., Pardo L., Lopez-Rodriguez M. Scientific Reports, 2017 (7), 41293.

Medina, R.A.; Vázquez-Villa, H M; Gómez-Tamayo, J.C.; Benhamú, B.; Martin-Fontecha, M.; de la Fuente, T; Caltabiano, G; Hedlund, P.B.; Pardo, L.; López-Rodríguez, M.L. Journal of Medicinal Chemistry, 2014, 57(15), 6879-6884.

“Benzimidazole derivatives as new serotonin 5-HT6 receptor antagonists. Molecular mechanisms of receptor inactivation”. Journal of Medicinal. Chemistry, 2010, 53, 1357.

“Benzimidazole derivatives as novel serotonin 5-HT6 receptor antagonists. A computacional and mutagenesis study of ligand-receptor interaction”. Drugs of the Future 2009, 34(Suppl. A), 217 (P161).

“Benzimidazole derivatives as novel serotonin 5-HT6 receptor antagonists. A computacional and mutagenesis study of ligand-receptor interaction”. Drugs of the Future 2008, 33(Suppl. A), 258 (P473).

Benzimidazole derivatives as novel serotonin 5-HT6 receptor ligands”. XV Congreso de la Sociedad Española de Química Terapéutica. El Escorial, 2007

“Design of novel 5-HT6R ligands using pharmacophore and ligand-receptor interaction models”. Lisboa (Portugal), 2007.

“Design of novel 5-HT6R ligands using pharmacophore and ligand-receptor interaction models”. International Symposium on Chemistry, Biology and Medicine. Paphos (Cyprus), 2006.

“A Three-Dimensional Pharmacophore Model for 5-Hydroxytryptamine 6 (5-HT6) Receptor Antagonists”, Journal of Medicinal. Chemistry, 2005, 48, 4219.

“Modelo de Farmacóforo de Antagonistas del Receptor Serotoninérgico 5-HT6.” Congreso: XIV Congreso Nacional Sociedad Española de Química Terapéutica. Bilbao (Leioa), 2005.

“Pharmacophore model and computational simulation for the recognition of serotonin 5-HT6R antagonists. 15th European Symposium on QSAR and Molecular Modelling in Rational Design of Bioactive Molecules”, Istanbul (Turkey). 2004.

“Pharmacophore model and computational simulation for the recognition of 5-HT6R antagonists”. EPHAR 2004-5th Serotonin Symposium. Oporto (Portugal), 2004.

“Asparaginase gene from Aspergillus nidulans”. XXII Fungal Genetics Conference. Asilomar (California), 2003.